SCHEMBL1106837

SCHEMBL1106837

CC(C)(CCC(N)=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.43
ACACB O00763 1/20 0.42
ACACA Q13085 1/20 0.42
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 3/20 0.35
KMT2A Q03164 2/20 0.35
GGT1 P19440 1/20 0.35
MEN1 O00255 1/20 0.35
THRB P10828 1/20 0.35
TSHR P16473 3/20 0.35
ALOX15 P16050 2/20 0.35
BLM P54132 2/20 0.35
PMP22 Q01453 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2C9 P11712 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GMNN O75496 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL232205 0.88 ACLY (0.52) ACLYACACBACACAALDH1A1CYP1A2
SCHEMBL154712 0.86 ACLY (0.55) ACLYACACBACACACYP1A2KMT2A
Hydrochloric Acid SCHEMBL561986 0.86 ACLY (0.50) ACLYACACBACACACYP1A2GGT1
Hydrochloric Acid SCHEMBL2867978 0.86 ACLY (0.50) ACLYACACBACACACYP1A2GGT1
SCHEMBL3293803 0.84 LMNA (0.38) ALDH1A1CYP1A2KMT2AMEN1ALOX15
SCHEMBL250911 0.84 ACLY (0.59) ACLYACACBACACACYP1A2KMT2A
Hydrochloric Acid SCHEMBL562371 0.84 ACLY (0.53) ACLYACACBACACACYP1A2KMT2A
Hydrochloric Acid SCHEMBL621977 0.84 ACLY (0.53) ACLYACACBACACACYP1A2KMT2A
Trifluoroacetic Acid SCHEMBL4530228 0.82 NOS1 (0.36) ACLYALDH1A1CYP1A2KMT2AGGT1
Hydrochloric Acid SCHEMBL561963 0.82 ACLY (0.57) ACLYACACBACACACYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3018126-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2016-05-11 EP disclosed
US-8153716-B2 Dispersant for an aqueous dispersion of positively charged or chargeable solid particulates which comprises a compound having an anchoring moiety linked to a polymeric hydrophilic moiety; inkjet recording element EASTMAN KODAK COMPANY (US) 2012-04-10 US disclosed
US-8063132-B2 Coating composition comprising boehmite particles and one or more dispersants and a method of coating a substrate using said coating composition EASTMAN KODAK COMPANY (US) 2011-11-22 US disclosed
EP-1933761-B1 INFLATABLE BIFURCATION STENT BOSTON SCIENT LTD (BB) 2010-11-24 EP disclosed
US-7785365-B2 Endovascular apparatus BOSTON SCIENTIFIC SCIMED, INC. (US) 2010-08-31 US disclosed
US-7731741-B2 Inflatable bifurcation stent BOSTON SCIENTIFIC SCIMED, INC. (US) 2010-06-08 US disclosed
US-7491230-B2 Endovascular apparatus BOSTON SCIENTIFIC SCIMED, INC. (US) 2009-02-17 US disclosed
EP-1933761-A1 INFLATABLE BIFURCATION STENT Boston Scientific Limited (BB) 2008-06-25 EP disclosed
US-20080145546-A1 Dispersant For Reducing Viscosity Of Particulate Solids FPC INC. 2008-06-19 US disclosed
US-20080090012-A1 Aqueous boehmite particles of a hydrophilic polymer having a linked anchoring moiety which contains acid(s) and/or hydroxy(s); the polymeric moiety has a lower affinity for a boehmite surface than the anchoring moiety; mercaptosuccinic acid-modified polyacrylamide; ink jet; paper coating; gloss porousity KODAK PHILIPPINES LTD. 2008-04-17 US disclosed
US-20030220684-A1 Endovascular apparatus SCIMED LIFE SYSTEMS, INC. (US) 2003-11-27 US disclosed
US-20030208257-A1 Endovascular apparatus HOLMAN THOMAS J (US) 2003-11-06 US disclosed
US-20030083738-A1 Endovascular apparatus HOLMAN THOMAS J (US) 2003-05-01 US disclosed
US-20020040235-A1 Endovascular apparatus HOLMAN THOMAS J (US) 2002-04-04 US disclosed
US-6319276-B1 Endovascular apparatus SCIMED LIFE SYSTEMS, INC. 2001-11-20 US disclosed
US-6059823-A Endovascular apparatus SCIMED LIFE SYSTEMS, INC. (US) 2000-05-09 US disclosed
EP-0959810-A1 ENDOVASCULAR APPARATUS SciMed Life Systems, Inc. (US) 1999-12-01 EP disclosed
US-5871537-A Endovascular apparatus SCIMED LIFE SYSTEMS, INC. (US) 1999-02-16 US disclosed
WO-1997029716-A1 ENDOVASCULAR APPARATUS SCIMED LIFE SYSTEMS, INC. (US) 1997-08-21 WO disclosed
US-4403037-A COATED WITH VIRUS ANTIGEN, STABILIZED AMERICAN HOECHST CORPORATION 1983-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090012-A1 Aqueous boehmite particles of a hydrophilic polymer having a linked anchoring moiety which contains acid(s) and/or hydroxy(s); the polymeric moiety has a lower affinity for a boehmite surface than the anchoring moiety; mercaptosuccinic acid-modified polyacrylamide; ink jet; paper coating; gloss porousity CD44, MPST, BHMT2 ACLY 4406/4885ACACB 4800/4885ACACA 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.